Expert Ratings for Alignment Healthcare
Over the past 3 months, 4 analysts have published their opinion on Alignment Healthcare (NASDAQ:ALHC) stock. These analysts…
Goldman Sachs Maintains Buy on Alignment Healthcare, Lowers Price Target to $14
Goldman Sachs analyst Nathan Rich maintains Alignment Healthcare (NASDAQ:ALHC) with a Buy and lowers the price target from $21 to $14.
Piper Sandler Maintains Overweight on Alignment Healthcare, Lowers Price Target to $12
Piper Sandler analyst Jessica Tassan maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $19 to $12.
JP Morgan Downgrades Alignment Healthcare to Neutral, Lowers Price Target to $12
JP Morgan analyst Lisa Gill downgrades Alignment Healthcare (NASDAQ:ALHC) from Overweight to Neutral and lowers the price target from $22 to $12.
Raymond James Downgrades Alignment Healthcare to Market Perform
Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Outperform to Market Perform.
Alignment Healthcare Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $360.30M Beat $333.40M Estimate
Alignment Healthcare (NASDAQ:ALHC) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is a 15.38 percent increase over losses of $(0.26) per share from
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.